Novartis Investigative Site

Chelmsford, Essex CM1 7ET

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Diabetes Mellitus and Heart Failure, Neoplasms, Breast

Studies at this site

• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure — Stopped early
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING